Colon Cancer Comprehensive Panel NGS Genetic Test
At DNA Labs UAE, we offer the Colon Cancer comprehensive panel NGS Genetic DNA Test at a cost of AED 4400.0. This test analyzes a patient’s DNA for mutations and variations in genes that are associated with an increased risk of developing colon cancer.
Test Details
The Colon Cancer comprehensive panel NGS Genetic DNA Test uses next-generation sequencing (NGS) technology to analyze multiple genes simultaneously, providing a comprehensive evaluation of a patient’s genetic risk for colon cancer. The test typically includes analysis of genes such as APC, MUTYH, MLH1, MSH2, MSH6, PMS2, and EPCAM, among others.
Mutations or variations in these genes have been associated with an increased risk of developing colon cancer and other related cancers.
Who Should Take This Test?
The Colon Cancer comprehensive panel NGS Genetic DNA Test is typically recommended for individuals with a personal or family history of colon cancer or other related cancers. It is also recommended for those with a suspected hereditary cancer syndrome.
This test can help identify individuals who may benefit from increased surveillance or preventative measures, such as earlier and more frequent colonoscopies or prophylactic surgery.
How the Test is Conducted
The test is performed on a sample of the patient’s blood or tissue. The sample can be in the form of blood, extracted DNA, or one drop of blood on an FTA card.
After the sample is collected, it is sent to our laboratory for analysis using NGS technology. The test typically takes 3 to 4 weeks for results to be delivered.
Interpreting the Results
Once the results are available, they are interpreted by a genetic counselor or medical professional. They can provide guidance on the implications of the results and any recommended follow-up actions.
Conclusion
The Colon Cancer comprehensive panel NGS Genetic DNA Test offered by DNA Labs UAE is a valuable tool in assessing an individual’s genetic risk for colon cancer. It provides comprehensive analysis of multiple genes associated with an increased risk of developing colon cancer and related cancers.
If you have a personal or family history of colon cancer or suspect a hereditary cancer syndrome, we recommend considering this test to identify potential preventative measures or increased surveillance that may be necessary for your health.
| Test Name | Colon Cancer comprehensive panel NGS Genetic DNA Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for Colon Cancer comprehensive panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APC, ATM, AXIN2, BLM, BMPR1A, BRCA1, BRCA2, CDH1, CDKN2A, CHEK2, EPCAM, FLCN, GALNT12, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NBN, NTHL1, PALB2, PMS2, POLD1, POLE, PRSS1, PTEN, RNF43, SMAD4, STK11, TGFBR2, TP53, VHL |
| Test Details | The Colon Cancer comprehensive panel NGS Genetic DNA Test is a genetic test that analyzes a patient’s DNA for mutations and variations in genes that are associated with an increased risk of developing colon cancer. The test uses next-generation sequencing (NGS) technology to analyze multiple genes simultaneously, providing a comprehensive evaluation of a patient’s genetic risk for colon cancer. The test typically includes analysis of genes such as APC, MUTYH, MLH1, MSH2, MSH6, PMS2, and EPCAM, among others. Mutations or variations in these genes have been associated with an increased risk of developing colon cancer and other related cancers. The Colon Cancer comprehensive panel NGS Genetic DNA Test is typically recommended for individuals with a personal or family history of colon cancer or other related cancers, as well as those with a suspected hereditary cancer syndrome. The test can help identify individuals who may benefit from increased surveillance or preventative measures, such as earlier and more frequent colonoscopies or prophylactic surgery. The test is performed on a sample of the patient’s blood or tissue, and results are typically available within a few weeks. The results are interpreted by a genetic counselor or medical professional, who can provide guidance on the implications of the results and any recommended follow-up actions. |
